background hbv infection is a serious public health problem worldwide, which can contribute to the incidence of chronic hepatitis b (chb), cirrhosis, and hepatocellular carcinoma (hcc). objectives in the present report, we assessed the association between adiponectin, its receptors and hepatic steatosis, fibrosis, and inflammation with hepatitis b virus. patients and methods liver biopsies from...

An estimated 71 million people worldwide are chronically infected with hepatitis C [1] and 257 million with hepatitis B [1–4]. Combined, hepatitis C and hepatitis B are estimated to cause 1.34 million deaths annually, and viral hepatitis is now the 7th leading cause of death globally, ahead of HIV and malaria [2, 3]. The burden of hepatitis B and C disease in 2013 was estimated at 38.7 million ...

AIMS To evaluate the role of hepatocyte expression of leucocyte adhesion molecules and major histocompatibility complex (MHC) antigens in the pathogenesis of chronic viral hepatitis. METHODS The expression of intercellular adhesion molecule 1 (ICAM-1), lymphocyte function associated antigen 3 (LFA-3), and MHC class I and II antigens on hepatocyte membrane in relation to the histological and b...

The review presents current data on the role of viral hepatitis B in oncohematological patients. Possible ways infection, prevention and activation this category patients are considered. specific features course various clinical situations described: against background other infections conduct anti-leukemia therapy.

This issue of Viral Hepatitis reviews the topics covered at the Viral Hepatitis Prevention Board (VHPB) autumn meeting held on November 17-18, 2005 in Edinburgh, United Kingdom (UK). The aim of the meeting was to review the current UK practice relating to the control of viral hepatitis. Health policy, healthcare delivery, decision-making, research, and funding in England, Wales, Scotland, and N...

background: it is estimated that about 370 million people are chronic carriers of hbv worldwide. apparently 3% of iranian populations are chronic carriers of this virus. we aimed to evaluate the viral dna in biological fluids of chronic hepatitis patients compared to a control group. methods: the current case-control study was designed to evaluate the viral dna in biological fluids of 70 chroni...

Hepatitis B is preventable and hepatitis C is treatable even if still at a high cost; most people who are infected with hepatitis B or C virus have not been screened yet and are unaware of their infections; and most countries, especially developing countries, do not have a national plan to prevent and control viral hepatitis. The advent of effective new treatments for hepatitis C has been an ag...

Hepatitis B virus (HBV) associated end-stage liver diseases are the leading causes of liver transplantation (LT) in Taiwan. Relapse of hepatitis B occurs after LT, raising the risk of graft failure and reducing patient survival. Although several oral antiviral agents have been approved for anti-HBV treatment, lamivudine (LAM) remained to be the most widely used preventive regimen in Taiwan. Whi...